Moxonidine in Patients Undergoing Vascular Surgery

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
Investigating the perioperative effect of moxonidine. In a randomized double-blind fashion, patients undergoing vascular surgery will receive moxonidine 0.2 mg or placebo from the day before surgery until day 4 after surgery. Holter-EKG for 48 h, starting just before surgery. Repeated 12-lead EKG, measurements of Troponin I and BNP, clinical visitations, follow-up interviews at 6 and 12 months
Epistemonikos ID: 03eb27c11ebfe6da5bdb97055d800223c9aa6fe2
First added on: May 04, 2024